Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Autoimmune Disorders

  Free Subscription


01.05.2017

1 Ann Neurol
1 Brain
1 Intern Med
1 J Autoimmun
1 J Immunol
1 J Pediatr
5 J Pediatr Endocrinol Metab
1 Lancet Neurol
2 Mult Scler
11 N Engl J Med
7 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Neurol

  1. ANDRODIAS G, Bernard E, Biotti D, Collongues N, et al
    Multiple sclerosis broke my heart.
    Ann Neurol. 2017 Apr 24. doi: 10.1002/ana.24935.
    PubMed     Text format     Abstract available


    Brain

  2. EL BEHI M, Sanson C, Bachelin C, Guillot-Noel L, et al
    Adaptive human immunity drives remyelination in a mouse model of demyelination.
    Brain. 2017;140:967-980.
    PubMed     Text format     Abstract available


    Intern Med

  3. TANAKA S, Hishiki M, Ogasawara J, Sorimachi E, et al
    The Deterioration of the Glycemic Profile during Hormone Replacement Therapy in a Patient with Fulminant Type 1 Diabetes.
    Intern Med. 2017;56:531-534.
    PubMed     Text format     Abstract available


    J Autoimmun

  4. GENERALI E, Ceribelli A, Stazi MA, Selmi C, et al
    Lessons learned from twins in autoimmune and chronic inflammatory diseases.
    J Autoimmun. 2017 Apr 18. pii: S0896-8411(17)30246.
    PubMed     Text format     Abstract available


    J Immunol

  5. KATSUYAMA E, Yan M, Watanabe KS, Matsushima S, et al
    Downregulation of miR-200a-3p, Targeting CtBP2, Is Involved in the Hypoproduction of IL-2 in Systemic Lupus Erythematosus-Derived T Cells.
    J Immunol. 2017 Apr 24. pii: 1601705. doi: 10.4049/jimmunol.1601705.
    PubMed     Text format     Abstract available


    J Pediatr

  6. HASHKES PJ
    Race and income affects outcomes in juvenile dermatomyositis.
    J Pediatr. 2017;184:2.
    PubMed     Text format    


    J Pediatr Endocrinol Metab

  7. HOFFMAN RP, Dye AS, Huang H, Bauer JA, et al
    Glycemic variability predicts inflammation in adolescents with type 1 diabetes.
    J Pediatr Endocrinol Metab. 2016;29:1129-1133.
    PubMed     Text format     Abstract available

  8. SZCZAPA-JAGUSTYN J, Gotz-Wieckowska A, Kociecki J
    An update on thyroid-associated ophthalmopathy in children and adolescents.
    J Pediatr Endocrinol Metab. 2016;29:1115-1122.
    PubMed     Text format     Abstract available

  9. KREBS A, Doerfer J, Krause A, Grulich-Henn J, et al
    Lipoprotein-associated phospholipase A2 activity and low-density lipoprotein subfractions after a 2-year treatment with atorvastatin in adolescents with type 1 diabetes.
    J Pediatr Endocrinol Metab. 2016;29:1181-1186.
    PubMed     Text format     Abstract available

  10. KEEL S, Itsiopoulos C, Koklanis K, Vukicevic M, et al
    Prevalence and risk factors for diabetic retinopathy in a hospital-based population of Australian children and adolescents with type 1 diabetes.
    J Pediatr Endocrinol Metab. 2016;29:1135-1142.
    PubMed     Text format     Abstract available

  11. SAAD HA, Patterson CC, Cardwell CR
    Systematic review and meta-analysis of the association between mumps during childhood and risk of type 1 diabetes mellitus.
    J Pediatr Endocrinol Metab. 2016;29:1123-1128.
    PubMed     Text format     Abstract available


    Lancet Neurol

  12. WIJNANDS JMA, Kingwell E, Zhu F, Zhao Y, et al
    Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort study.
    Lancet Neurol. 2017 Apr 20. pii: S1474-4422(17)30076.
    PubMed     Text format     Abstract available


    Mult Scler

  13. TOUSSAINT-DUYSTER LC, Wong YYM, Van der Cammen-van Zijp MH, Van Pelt-Gravesteijn D, et al
    Fatigue and physical functioning in children with multiple sclerosis and acute disseminated encephalomyelitis.
    Mult Scler. 2017 Apr 1:1352458517706038. doi: 10.1177/1352458517706038.
    PubMed     Text format     Abstract available

  14. HAGENS MH, Killestein J, Yaqub MM, van Dongen GA, et al
    Cerebral rituximab uptake in multiple sclerosis: A 89Zr-immunoPET pilot study.
    Mult Scler. 2017 Apr 1:1352458517704507. doi: 10.1177/1352458517704507.
    PubMed     Text format     Abstract available


    N Engl J Med

  15. HAUSER SL, Belachew Sh, Kappos L
    Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
    N Engl J Med. 2017;376:1694.
    PubMed     Text format    

  16. SCHOERGENHOFER C, Jilma B
    Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
    N Engl J Med. 2017;376:1693.
    PubMed     Text format    

  17. MONTALBAN X, Belachew S, Wolinsky JS
    Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
    N Engl J Med. 2017;376:1694.
    PubMed     Text format    

  18. KORN T, Oukka M
    A BAFFling Association between Malaria Resistance and the Risk of Multiple Sclerosis.
    N Engl J Med. 2017;376:1680-1681.
    PubMed     Text format    

  19. STERI M, Orru V, Idda ML, Pitzalis M, et al
    Overexpression of the Cytokine BAFF and Autoimmunity Risk.
    N Engl J Med. 2017;376:1615-1626.
    PubMed     Text format     Abstract available

  20. SHARP MK
    Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
    N Engl J Med. 2017;376:1692.
    PubMed     Text format    

  21. MILDINER S, Malnick S
    Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
    N Engl J Med. 2017;376:1692-3.
    PubMed     Text format    

  22. DEISENHAMMER F, Auer M, Hegen H
    Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
    N Engl J Med. 2017;376:1693-4.
    PubMed     Text format    

  23. LAVERY K, Gilden DJ, Saint S, Judson MA, et al
    A Bare-Bones Approach.
    N Engl J Med. 2017;376:1371-1376.
    PubMed     Text format    

  24. RAWSHANI A, Rawshani A, Franzen S, Eliasson B, et al
    Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
    N Engl J Med. 2017;376:1407-1418.
    PubMed     Text format     Abstract available

  25. MAYER-DAVIS EJ, Lawrence JM, Dabelea D, Divers J, et al
    Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012.
    N Engl J Med. 2017;376:1419-1429.
    PubMed     Text format     Abstract available


    PLoS One

  26. LI JN, Jia X, Wang Y, Xie C, et al
    Plasma from patients with anti-glomerular basement membrane disease could recognize microbial peptides.
    PLoS One. 2017;12:e0174553.
    PubMed     Text format     Abstract available

  27. HO TW, Huang CT, Ruan SY, Tsai YJ, et al
    Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortality.
    PLoS One. 2017;12:e0175794.
    PubMed     Text format     Abstract available

  28. NAVAS-MADRONAL M, Valero-Mut A, Martinez-Zapata MJ, Simon-Talero MJ, et al
    Absence of antibodies against KIR4.1 in multiple sclerosis: A three-technique approach and systematic review.
    PLoS One. 2017;12:e0175538.
    PubMed     Text format     Abstract available

  29. ZHANG JJ, Yu GZ, Zheng ZH, Liu YF, et al
    Dividing CKD stage 3 into G3a and G3b could better predict the prognosis of IgA nephropathy.
    PLoS One. 2017;12:e0175828.
    PubMed     Text format     Abstract available

  30. DE MACEDO MSFC, Costa KM, da Silva Filho M
    Voice disorder in systemic lupus erythematosus.
    PLoS One. 2017;12:e0175893.
    PubMed     Text format     Abstract available

  31. SHARMA S, Zhang Y
    Fourier transform power spectrum is a potential measure of tissue alignment in standard MRI: A multiple sclerosis study.
    PLoS One. 2017;12:e0175979.
    PubMed     Text format     Abstract available

  32. HINTSA S, Dube L, Abay M, Angesom T, et al
    Determinants of diabetic nephropathy in Ayder Referral Hospital, Northern Ethiopia: A case-control study.
    PLoS One. 2017;12:e0173566.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  33. ROGERS JA, Mishra MK, Hahn J, Greene CJ, et al
    Gestational bisphenol-A exposure lowers the threshold for autoimmunity in a model of multiple sclerosis.
    Proc Natl Acad Sci U S A. 2017 Apr 24. pii: 201620774.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: